EverSource Wealth Advisors LLC raised its position in Relx Plc (NYSE:RELX – Free Report) by 83.3% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 10,613 shares of the technology company’s stock after purchasing an additional 4,824 shares during the period. EverSource Wealth Advisors LLC’s holdings in Relx were worth $482,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also modified their holdings of RELX. CENTRAL TRUST Co raised its holdings in shares of Relx by 1,290.2% in the fourth quarter. CENTRAL TRUST Co now owns 570 shares of the technology company’s stock valued at $26,000 after buying an additional 529 shares during the last quarter. Versant Capital Management Inc purchased a new stake in Relx during the 4th quarter valued at approximately $31,000. Sierra Ocean LLC acquired a new stake in Relx during the 4th quarter worth approximately $43,000. Private Trust Co. NA grew its stake in shares of Relx by 119.9% in the 3rd quarter. Private Trust Co. NA now owns 1,038 shares of the technology company’s stock valued at $49,000 after purchasing an additional 566 shares during the last quarter. Finally, Whipplewood Advisors LLC acquired a new position in shares of Relx in the fourth quarter valued at approximately $74,000. 15.02% of the stock is owned by institutional investors and hedge funds.
Relx Stock Up 2.5 %
Relx stock opened at $48.99 on Friday. The stock’s 50 day moving average price is $48.86 and its 200 day moving average price is $47.59. Relx Plc has a 1-year low of $40.25 and a 1-year high of $51.99. The company has a market cap of $91.04 billion, a PE ratio of 26.34, a price-to-earnings-growth ratio of 2.73 and a beta of 0.90. The company has a debt-to-equity ratio of 1.46, a current ratio of 0.52 and a quick ratio of 0.47.
Relx Increases Dividend
Wall Street Analyst Weigh In
Several brokerages recently weighed in on RELX. StockNews.com downgraded Relx from a “buy” rating to a “hold” rating in a report on Tuesday, March 4th. Barclays upgraded shares of Relx from an “equal weight” rating to an “overweight” rating in a research note on Friday. Finally, Redburn Atlantic began coverage on shares of Relx in a research note on Wednesday, January 8th. They set a “buy” rating on the stock.
Read Our Latest Stock Report on RELX
About Relx
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Featured Stories
- Five stocks we like better than Relx
- What Is WallStreetBets and What Stocks Are They Targeting?
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- What is MarketRank™? How to Use it
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- The 3 Best Retail Stocks to Shop for in August
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Free Report).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.